Taisho Pharmaceutical Holdings Co., Ltd. Stock price

Equities

4581

JP3442850008

Pharmaceuticals

Delayed Japan Exchange 08:28:14 2024-02-21 pm EST 5-day change 1st Jan Change
8,592 JPY -0.02% Intraday chart for Taisho Pharmaceutical Holdings Co., Ltd. +0.06% -0.58%
Sales 2024 * 318B 2.12B Sales 2025 * 326B 2.17B Capitalization 704B 4.68B
Net income 2024 * 9.3B 61.84M Net income 2025 * 18.1B 120M EV / Sales 2024 * 1.39 x
Net cash position 2024 * 261B 1.73B Net cash position 2025 * 279B 1.86B EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
75.8 x
P/E ratio 2025 *
38.9 x
Employees 8,784
Yield 2024 *
1.16%
Yield 2025 *
1.16%
Free-Float 53.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.01%
1 week+0.06%
Current month-0.08%
1 month-0.13%
3 months+55.79%
6 months+43.08%
Current year-0.58%
More quotes
1 week
8 586.00
Extreme 8586
8 607.00
1 month
8 583.00
Extreme 8583
8 640.00
Current year
8 570.00
Extreme 8570
8 677.00
1 year
5 150.00
Extreme 5150
8 753.00
3 years
4 560.00
Extreme 4560
8 753.00
5 years
4 560.00
Extreme 4560
11 440.00
10 years
4 560.00
Extreme 4560
14 130.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
President 82 11-10-02
Chief Tech/Sci/R&D Officer 46 11-10-02
Members of the board TitleAgeSince
Director/Board Member 82 11-10-02
President 82 11-10-02
Director/Board Member 77 11-10-02
More insiders
Date Price Change Volume
24-02-21 8,592 -0.02% 15 000
24-02-21 8,594 0.00% 75,900
24-02-20 8,594 +0.01% 242,300
24-02-19 8,593 +0.02% 94,600
24-02-16 8,591 -0.05% 125,200

Delayed Quote Japan Exchange, February 21, 2024 at 08:28 pm EST

More quotes
Taisho Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The Company operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8,594 JPY
Average target price
6,180 JPY
Spread / Average Target
-28.09%
Consensus
  1. Stock
  2. Equities
  3. Stock Taisho Pharmaceutical Holdings Co., Ltd. - Japan Exchange
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer